Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study
Authors
Keywords
-
Journal
SUPPORTIVE CARE IN CANCER
Volume 30, Issue 2, Pages 1807-1814
Publisher
Springer Science and Business Media LLC
Online
2021-10-02
DOI
10.1007/s00520-021-06509-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence of cognitive impairment and change in patients with breast cancer: A systematic review of longitudinal studies
- (2021) Aicha B. C. Dijkshoorn et al. PSYCHO-ONCOLOGY
- Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice
- (2021) C. Meregalli et al. NEUROSCIENCE LETTERS
- Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults
- (2020) Claus Vinter Bødker Hviid et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Plasma Neurofilament Light Chain May Be a Biomarker for the Inverse Association Between Cancers and Neurodegenerative Diseases
- (2020) Shunjie Liu et al. Frontiers in Aging Neuroscience
- Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity
- (2020) Cristina Meregalli et al. ARCHIVES OF TOXICOLOGY
- Electroacupuncture trigeminal nerve stimulation plus body acupuncture for chemotherapy-induced cognitive impairment in breast cancer patients: An assessor-participant blinded, randomized controlled trial
- (2020) Zhang-Jin Zhang et al. BRAIN BEHAVIOR AND IMMUNITY
- Serum neurofilament light chain studies in neurological disorders, hints for interpretation
- (2020) Sara Mariotto et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Neurofilament Light Chain as A Biomarker for Brain Metastases
- (2020) Anne Winther-Larsen et al. Cancers
- Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
- (2020) Samantha J. Mayo et al. SUPPORTIVE CARE IN CANCER
- Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
- (2019) Jens Kuhle et al. NEUROLOGY
- Neurofilament light chain as a biomarker in neurological disorders
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Normative Data for the Montreal Cognitive Assessment in Greek Older Adults With Subjective Cognitive Decline, Mild Cognitive Impairment and Dementia
- (2019) Eleni Poptsi et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
- (2019) M Lange et al. ANNALS OF ONCOLOGY
- Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis
- (2019) Mahima Kapoor et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy
- (2018) Cristina Meregalli et al. EXPERIMENTAL NEUROLOGY
- Serum and CSF neurofilament light chain levels in patients with acquired peripheral neuropathies
- (2018) Sara Mariotto et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors
- (2017) Hélène Castel et al. Frontiers in Pharmacology
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- The perceptions of Australian oncologists about cognitive changes in cancer survivors
- (2016) Kate Smidt et al. SUPPORTIVE CARE IN CANCER
- Potential Role of pNF-H, a Biomarker of Axonal Damage in the Central Nervous System, as a Predictive Marker of Chemotherapy-Induced Cognitive Impairment
- (2015) A. Natori et al. CLINICAL CANCER RESEARCH
- Chemotherapy-related changes in cognitive functioning
- (2013) Sanne B. Schagen et al. EJC SUPPLEMENTS
- Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study
- (2013) YanHong Dong et al. INTERNATIONAL PSYCHOGERIATRICS
- Chemobrain: A systematic review of structural and functional neuroimaging studies
- (2013) Marta Simó et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment
- (2013) Christine D. Craig et al. SUPPORTIVE CARE IN CANCER
- Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science
- (2012) Tim A. Ahles et al. JOURNAL OF CLINICAL ONCOLOGY
- An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors
- (2012) Yin Ting Cheung et al. SUPPORTIVE CARE IN CANCER
- Montreal Cognitive Assessment
- (2011) Sandra Freitas et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
- (2011) Jeffrey S Wefel et al. LANCET ONCOLOGY
- Psychometric Evaluation of the Montreal Cognitive Assessment (MoCA) in Three Diverse Samples
- (2010) Ira H. Bernstein et al. CLINICAL NEUROPSYCHOLOGIST
- Either Called “Chemobrain” or “Chemofog,” the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is Real
- (2010) Andreas A. Argyriou et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research
- (2010) Riejanne Seigers et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Review of the Multiple Aspects of Neurofilament Functions, and their Possible Contribution to Neurodegeneration
- (2008) Rodolphe Perrot et al. MOLECULAR NEUROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now